10.1002/cbin.10543 Summary Keywords berberine, berberine metabolite, intestinal-hepatic-vascular tissue, pharmacological mechanism, lipid metabolic disease Citation Cai Y, Yang Q, Yu Y, Yang F, Bai R and Fan X (2023) Efficacy and underlying mechanisms of berberine against lipid metabolic diseases: a review
Add to basket You may also be interested in
It is the first approval beyond obesity treatment for Zepbound, which entered the market late last year and is also being tested for several other obesity-related conditions, such as fatty liver disease
Rapid weight loss raises concerns : Quick weight loss can sometimes lead to complications like gallstones or gallbladder problems
doi: 10.1186/1477-7525-4-1 8 BensonPR
Dual-energy X-ray absorptiometry (DXA) Areal BMDs of the lumbar spine (L1L4), hip, and whole body were measured on separate days, at baseline and after 12-week RT